Melco International Development Limited (MDEVY) Stock Competitors & Peer Comparison
See (MDEVY) competitors and their performances in Stock Market.
Peer Comparison Table: Gambling, Resorts & Casinos Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDEVY | $2.23 | +0.00% | 672.2M | 7.19 | $0.31 | +30.80% |
| PDYPY | $103.75 | +0.50% | 36.7B | -494.05 | -$0.21 | N/A |
| PDYPF | $205.00 | +1.98% | 36.3B | -476.74 | -$0.43 | N/A |
| ARLUF | $33.85 | +0.00% | 20.4B | 19.91 | $1.70 | +2.00% |
| GXYEF | $4.01 | -3.95% | 17.6B | 12.94 | $0.31 | +4.79% |
| GXYYY | $19.50 | -4.13% | 17.1B | 12.63 | $1.55 | +4.91% |
| SCHYF | $2.04 | +0.00% | 16.5B | 18.55 | $0.11 | +4.70% |
| SCHYY | $19.15 | -4.49% | 15.5B | 17.27 | $1.11 | +5.00% |
| EVGGF | $76.25 | +4.58% | 15.1B | 12.50 | $6.10 | N/A |
| EVVTY | $73.18 | -3.10% | 14.5B | 12.00 | $6.10 | N/A |
Stock Comparison
MDEVY vs PDYPY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PDYPY has a market cap of 36.7B. Regarding current trading prices, MDEVY is priced at $2.23, while PDYPY trades at $103.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PDYPY's P/E ratio is -494.05. In terms of profitability, MDEVY's ROE is +0.73%, compared to PDYPY's ROE of -0.03%. Regarding short-term risk, MDEVY is more volatile compared to PDYPY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PDYPY's competition here
MDEVY vs PDYPF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PDYPF has a market cap of 36.3B. Regarding current trading prices, MDEVY is priced at $2.23, while PDYPF trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PDYPF's P/E ratio is -476.74. In terms of profitability, MDEVY's ROE is +0.73%, compared to PDYPF's ROE of -0.03%. Regarding short-term risk, MDEVY is more volatile compared to PDYPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PDYPF's competition here
MDEVY vs ARLUF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ARLUF has a market cap of 20.4B. Regarding current trading prices, MDEVY is priced at $2.23, while ARLUF trades at $33.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ARLUF's P/E ratio is 19.91. In terms of profitability, MDEVY's ROE is +0.73%, compared to ARLUF's ROE of +0.23%. Regarding short-term risk, MDEVY is more volatile compared to ARLUF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check ARLUF's competition here
MDEVY vs GXYEF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GXYEF has a market cap of 17.6B. Regarding current trading prices, MDEVY is priced at $2.23, while GXYEF trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GXYEF's P/E ratio is 12.94. In terms of profitability, MDEVY's ROE is +0.73%, compared to GXYEF's ROE of +0.13%. Regarding short-term risk, MDEVY is more volatile compared to GXYEF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GXYEF's competition here
MDEVY vs GXYYY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GXYYY has a market cap of 17.1B. Regarding current trading prices, MDEVY is priced at $2.23, while GXYYY trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GXYYY's P/E ratio is 12.63. In terms of profitability, MDEVY's ROE is +0.73%, compared to GXYYY's ROE of +0.13%. Regarding short-term risk, MDEVY is more volatile compared to GXYYY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GXYYY's competition here
MDEVY vs SCHYF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SCHYF has a market cap of 16.5B. Regarding current trading prices, MDEVY is priced at $2.23, while SCHYF trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SCHYF's P/E ratio is 18.55. In terms of profitability, MDEVY's ROE is +0.73%, compared to SCHYF's ROE of +0.71%. Regarding short-term risk, MDEVY is more volatile compared to SCHYF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SCHYF's competition here
MDEVY vs SCHYY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SCHYY has a market cap of 15.5B. Regarding current trading prices, MDEVY is priced at $2.23, while SCHYY trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SCHYY's P/E ratio is 17.27. In terms of profitability, MDEVY's ROE is +0.73%, compared to SCHYY's ROE of +0.71%. Regarding short-term risk, MDEVY is more volatile compared to SCHYY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SCHYY's competition here
MDEVY vs EVGGF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EVGGF has a market cap of 15.1B. Regarding current trading prices, MDEVY is priced at $2.23, while EVGGF trades at $76.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EVGGF's P/E ratio is 12.50. In terms of profitability, MDEVY's ROE is +0.73%, compared to EVGGF's ROE of +0.27%. Regarding short-term risk, MDEVY is more volatile compared to EVGGF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check EVGGF's competition here
MDEVY vs EVVTY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EVVTY has a market cap of 14.5B. Regarding current trading prices, MDEVY is priced at $2.23, while EVVTY trades at $73.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EVVTY's P/E ratio is 12.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to EVVTY's ROE of +0.27%. Regarding short-term risk, MDEVY is more volatile compared to EVVTY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check EVVTY's competition here
MDEVY vs GEBHF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GEBHF has a market cap of 10.4B. Regarding current trading prices, MDEVY is priced at $2.23, while GEBHF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GEBHF's P/E ratio is 54.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to GEBHF's ROE of +0.00%. Regarding short-term risk, MDEVY is more volatile compared to GEBHF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GEBHF's competition here
MDEVY vs LTRCF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, LTRCF has a market cap of 8.4B. Regarding current trading prices, MDEVY is priced at $2.23, while LTRCF trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas LTRCF's P/E ratio is 31.63. In terms of profitability, MDEVY's ROE is +0.73%, compared to LTRCF's ROE of +1.10%. Regarding short-term risk, MDEVY is more volatile compared to LTRCF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check LTRCF's competition here
MDEVY vs LNWO Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, LNWO has a market cap of 6.4B. Regarding current trading prices, MDEVY is priced at $2.23, while LNWO trades at $80.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas LNWO's P/E ratio is 27.11. In terms of profitability, MDEVY's ROE is +0.73%, compared to LNWO's ROE of +0.50%. Regarding short-term risk, MDEVY is more volatile compared to LNWO. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check LNWO's competition here
MDEVY vs GIGNF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GIGNF has a market cap of 6B. Regarding current trading prices, MDEVY is priced at $2.23, while GIGNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GIGNF's P/E ratio is 16.67. In terms of profitability, MDEVY's ROE is +0.73%, compared to GIGNF's ROE of +0.04%. Regarding short-term risk, MDEVY is more volatile compared to GIGNF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GIGNF's competition here
MDEVY vs GIGNY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GIGNY has a market cap of 5.9B. Regarding current trading prices, MDEVY is priced at $2.23, while GIGNY trades at $24.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GIGNY's P/E ratio is 19.44. In terms of profitability, MDEVY's ROE is +0.73%, compared to GIGNY's ROE of +0.04%. Regarding short-term risk, MDEVY is more volatile compared to GIGNY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GIGNY's competition here
MDEVY vs MCHVF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, MCHVF has a market cap of 5.7B. Regarding current trading prices, MDEVY is priced at $2.23, while MCHVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas MCHVF's P/E ratio is 10.71. In terms of profitability, MDEVY's ROE is +0.73%, compared to MCHVF's ROE of +1.95%. Regarding short-term risk, MDEVY is more volatile compared to MCHVF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check MCHVF's competition here
MDEVY vs GOFPY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GOFPY has a market cap of 5.6B. Regarding current trading prices, MDEVY is priced at $2.23, while GOFPY trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GOFPY's P/E ratio is 9.99. In terms of profitability, MDEVY's ROE is +0.73%, compared to GOFPY's ROE of +0.99%. Regarding short-term risk, MDEVY is more volatile compared to GOFPY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GOFPY's competition here
MDEVY vs MCHVY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, MCHVY has a market cap of 5.4B. Regarding current trading prices, MDEVY is priced at $2.23, while MCHVY trades at $17.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas MCHVY's P/E ratio is 8.44. In terms of profitability, MDEVY's ROE is +0.73%, compared to MCHVY's ROE of +1.94%. Regarding short-term risk, MDEVY is more volatile compared to MCHVY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check MCHVY's competition here
MDEVY vs LFDJF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, LFDJF has a market cap of 4.9B. Regarding current trading prices, MDEVY is priced at $2.23, while LFDJF trades at $26.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas LFDJF's P/E ratio is 24.03. In terms of profitability, MDEVY's ROE is +0.73%, compared to LFDJF's ROE of +0.19%. Regarding short-term risk, MDEVY is more volatile compared to LFDJF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check LFDJF's competition here
MDEVY vs GMVHF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GMVHF has a market cap of 4.9B. Regarding current trading prices, MDEVY is priced at $2.23, while GMVHF trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GMVHF's P/E ratio is -5.44. In terms of profitability, MDEVY's ROE is +0.73%, compared to GMVHF's ROE of -0.57%. Regarding short-term risk, MDEVY is more volatile compared to GMVHF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GMVHF's competition here
MDEVY vs GMVHY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GMVHY has a market cap of 4.7B. Regarding current trading prices, MDEVY is priced at $2.23, while GMVHY trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GMVHY's P/E ratio is -5.19. In terms of profitability, MDEVY's ROE is +0.73%, compared to GMVHY's ROE of -0.57%. Regarding short-term risk, MDEVY is more volatile compared to GMVHY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GMVHY's competition here
MDEVY vs WYNMY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, WYNMY has a market cap of 3.9B. Regarding current trading prices, MDEVY is priced at $2.23, while WYNMY trades at $7.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas WYNMY's P/E ratio is 18.44. In terms of profitability, MDEVY's ROE is +0.73%, compared to WYNMY's ROE of -0.12%. Regarding short-term risk, MDEVY is more volatile compared to WYNMY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check WYNMY's competition here
MDEVY vs WYNMF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, WYNMF has a market cap of 3.8B. Regarding current trading prices, MDEVY is priced at $2.23, while WYNMF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas WYNMF's P/E ratio is 18.11. In terms of profitability, MDEVY's ROE is +0.73%, compared to WYNMF's ROE of -0.12%. Regarding short-term risk, MDEVY is more volatile compared to WYNMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check WYNMF's competition here
MDEVY vs BMRMF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BMRMF has a market cap of 3.4B. Regarding current trading prices, MDEVY is priced at $2.23, while BMRMF trades at $137.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BMRMF's P/E ratio is 24.46. In terms of profitability, MDEVY's ROE is +0.73%, compared to BMRMF's ROE of +0.07%. Regarding short-term risk, MDEVY is more volatile compared to BMRMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check BMRMF's competition here
MDEVY vs GMALY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GMALY has a market cap of 3.2B. Regarding current trading prices, MDEVY is priced at $2.23, while GMALY trades at $14.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GMALY's P/E ratio is 82.65. In terms of profitability, MDEVY's ROE is +0.73%, compared to GMALY's ROE of +0.06%. Regarding short-term risk, MDEVY is more volatile compared to GMALY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GMALY's competition here
MDEVY vs GMALF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GMALF has a market cap of 2.8B. Regarding current trading prices, MDEVY is priced at $2.23, while GMALF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GMALF's P/E ratio is 16.40. In terms of profitability, MDEVY's ROE is +0.73%, compared to GMALF's ROE of +0.06%. Regarding short-term risk, MDEVY is more volatile compared to GMALF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GMALF's competition here
MDEVY vs SKXJF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SKXJF has a market cap of 2.6B. Regarding current trading prices, MDEVY is priced at $2.23, while SKXJF trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SKXJF's P/E ratio is 9.51. In terms of profitability, MDEVY's ROE is +0.73%, compared to SKXJF's ROE of +0.24%. Regarding short-term risk, MDEVY is more volatile compared to SKXJF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SKXJF's competition here
MDEVY vs KNDGF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, KNDGF has a market cap of 2.6B. Regarding current trading prices, MDEVY is priced at $2.23, while KNDGF trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas KNDGF's P/E ratio is 49.04. In terms of profitability, MDEVY's ROE is +0.73%, compared to KNDGF's ROE of +0.09%. Regarding short-term risk, MDEVY is more volatile compared to KNDGF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check KNDGF's competition here
MDEVY vs NGCRY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, NGCRY has a market cap of 2.5B. Regarding current trading prices, MDEVY is priced at $2.23, while NGCRY trades at $33.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas NGCRY's P/E ratio is 7.96. In terms of profitability, MDEVY's ROE is +0.73%, compared to NGCRY's ROE of +0.13%. Regarding short-term risk, MDEVY is more volatile compared to NGCRY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check NGCRY's competition here
MDEVY vs NGCRF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, NGCRF has a market cap of 2.3B. Regarding current trading prices, MDEVY is priced at $2.23, while NGCRF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas NGCRF's P/E ratio is 7.43. In terms of profitability, MDEVY's ROE is +0.73%, compared to NGCRF's ROE of +0.13%. Regarding short-term risk, MDEVY is more volatile compared to NGCRF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check NGCRF's competition here
MDEVY vs GEBEY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GEBEY has a market cap of 2.3B. Regarding current trading prices, MDEVY is priced at $2.23, while GEBEY trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GEBEY's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to GEBEY's ROE of +0.00%. Regarding short-term risk, MDEVY is more volatile compared to GEBEY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GEBEY's competition here
MDEVY vs GEBHY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GEBHY has a market cap of 2.3B. Regarding current trading prices, MDEVY is priced at $2.23, while GEBHY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GEBHY's P/E ratio is 97.67. In terms of profitability, MDEVY's ROE is +0.73%, compared to GEBHY's ROE of +0.00%. Regarding short-term risk, MDEVY is more volatile compared to GEBHY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GEBHY's competition here
MDEVY vs TABCF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, TABCF has a market cap of 1.8B. Regarding current trading prices, MDEVY is priced at $2.23, while TABCF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas TABCF's P/E ratio is 80.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to TABCF's ROE of +0.03%. Regarding short-term risk, MDEVY is more volatile compared to TABCF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check TABCF's competition here
MDEVY vs SJMHF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SJMHF has a market cap of 1.7B. Regarding current trading prices, MDEVY is priced at $2.23, while SJMHF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SJMHF's P/E ratio is -24.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to SJMHF's ROE of -0.03%. Regarding short-term risk, MDEVY is more volatile compared to SJMHF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SJMHF's competition here
MDEVY vs SJMHY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SJMHY has a market cap of 1.6B. Regarding current trading prices, MDEVY is priced at $2.23, while SJMHY trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SJMHY's P/E ratio is -30.67. In terms of profitability, MDEVY's ROE is +0.73%, compared to SJMHY's ROE of -0.03%. Regarding short-term risk, MDEVY is more volatile compared to SJMHY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SJMHY's competition here
MDEVY vs PYTCY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PYTCY has a market cap of 1.4B. Regarding current trading prices, MDEVY is priced at $2.23, while PYTCY trades at $9.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PYTCY's P/E ratio is -7.48. In terms of profitability, MDEVY's ROE is +0.73%, compared to PYTCY's ROE of +1.02%. Regarding short-term risk, MDEVY is more volatile compared to PYTCY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PYTCY's competition here
MDEVY vs BVHBB Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BVHBB has a market cap of 1.3B. Regarding current trading prices, MDEVY is priced at $2.23, while BVHBB trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BVHBB's P/E ratio is 22.57. In terms of profitability, MDEVY's ROE is +0.73%, compared to BVHBB's ROE of +0.31%. Regarding short-term risk, MDEVY is more volatile compared to BVHBB. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check BVHBB's competition here
MDEVY vs PYTCF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PYTCF has a market cap of 1.3B. Regarding current trading prices, MDEVY is priced at $2.23, while PYTCF trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PYTCF's P/E ratio is 36.77. In terms of profitability, MDEVY's ROE is +0.73%, compared to PYTCF's ROE of +1.01%. Regarding short-term risk, MDEVY is more volatile compared to PYTCF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PYTCF's competition here
MDEVY vs AGTEF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, AGTEF has a market cap of 1.2B. Regarding current trading prices, MDEVY is priced at $2.23, while AGTEF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas AGTEF's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to AGTEF's ROE of -0.06%. Regarding short-term risk, MDEVY is more volatile compared to AGTEF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check AGTEF's competition here
MDEVY vs MDEVF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, MDEVF has a market cap of 1B. Regarding current trading prices, MDEVY is priced at $2.23, while MDEVF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas MDEVF's P/E ratio is 7.67. In terms of profitability, MDEVY's ROE is +0.73%, compared to MDEVF's ROE of +0.73%. Regarding short-term risk, MDEVY is more volatile compared to MDEVF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check MDEVF's competition here
MDEVY vs TACBY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, TACBY has a market cap of 972.2M. Regarding current trading prices, MDEVY is priced at $2.23, while TACBY trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas TACBY's P/E ratio is 18.75. In terms of profitability, MDEVY's ROE is +0.73%, compared to TACBY's ROE of -0.70%. Regarding short-term risk, MDEVY is more volatile compared to TACBY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check TACBY's competition here
MDEVY vs BJSAF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BJSAF has a market cap of 806.1M. Regarding current trading prices, MDEVY is priced at $2.23, while BJSAF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BJSAF's P/E ratio is 35.34. In terms of profitability, MDEVY's ROE is +0.73%, compared to BJSAF's ROE of +0.19%. Regarding short-term risk, MDEVY is more volatile compared to BJSAF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check BJSAF's competition here
MDEVY vs IRLTY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, IRLTY has a market cap of 784.4M. Regarding current trading prices, MDEVY is priced at $2.23, while IRLTY trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas IRLTY's P/E ratio is 12.22. In terms of profitability, MDEVY's ROE is +0.73%, compared to IRLTY's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to IRLTY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check IRLTY's competition here
MDEVY vs RANKF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, RANKF has a market cap of 469.4M. Regarding current trading prices, MDEVY is priced at $2.23, while RANKF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas RANKF's P/E ratio is 9.11. In terms of profitability, MDEVY's ROE is +0.73%, compared to RANKF's ROE of +0.09%. Regarding short-term risk, MDEVY is more volatile compared to RANKF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check RANKF's competition here
MDEVY vs KMBIF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, KMBIF has a market cap of 424.2M. Regarding current trading prices, MDEVY is priced at $2.23, while KMBIF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas KMBIF's P/E ratio is 57.14. In terms of profitability, MDEVY's ROE is +0.73%, compared to KMBIF's ROE of +0.05%. Regarding short-term risk, MDEVY is more volatile compared to KMBIF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check KMBIF's competition here
MDEVY vs BYNEF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BYNEF has a market cap of 386.8M. Regarding current trading prices, MDEVY is priced at $2.23, while BYNEF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BYNEF's P/E ratio is 11.16. In terms of profitability, MDEVY's ROE is +0.73%, compared to BYNEF's ROE of +0.04%. Regarding short-term risk, MDEVY is more volatile compared to BYNEF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check BYNEF's competition here
MDEVY vs AINSF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, AINSF has a market cap of 326.7M. Regarding current trading prices, MDEVY is priced at $2.23, while AINSF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas AINSF's P/E ratio is -24.25. In terms of profitability, MDEVY's ROE is +0.73%, compared to AINSF's ROE of -0.06%. Regarding short-term risk, MDEVY is more volatile compared to AINSF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check AINSF's competition here
MDEVY vs SKYZF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SKYZF has a market cap of 319.6M. Regarding current trading prices, MDEVY is priced at $2.23, while SKYZF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SKYZF's P/E ratio is 18.45. In terms of profitability, MDEVY's ROE is +0.73%, compared to SKYZF's ROE of +0.02%. Regarding short-term risk, MDEVY is more volatile compared to SKYZF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SKYZF's competition here
MDEVY vs PBKOF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PBKOF has a market cap of 310.5M. Regarding current trading prices, MDEVY is priced at $2.23, while PBKOF trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PBKOF's P/E ratio is 16.62. In terms of profitability, MDEVY's ROE is +0.73%, compared to PBKOF's ROE of +0.07%. Regarding short-term risk, MDEVY is more volatile compared to PBKOF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PBKOF's competition here
MDEVY vs BLBRF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BLBRF has a market cap of 241.7M. Regarding current trading prices, MDEVY is priced at $2.23, while BLBRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BLBRF's P/E ratio is -2.10. In terms of profitability, MDEVY's ROE is +0.73%, compared to BLBRF's ROE of -0.10%. Regarding short-term risk, MDEVY is less volatile compared to BLBRF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check BLBRF's competition here
MDEVY vs EIHDF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EIHDF has a market cap of 229.6M. Regarding current trading prices, MDEVY is priced at $2.23, while EIHDF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EIHDF's P/E ratio is -0.31. In terms of profitability, MDEVY's ROE is +0.73%, compared to EIHDF's ROE of +1.26%. Regarding short-term risk, MDEVY is more volatile compared to EIHDF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check EIHDF's competition here
MDEVY vs GHIFF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GHIFF has a market cap of 202.2M. Regarding current trading prices, MDEVY is priced at $2.23, while GHIFF trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GHIFF's P/E ratio is 14.60. In terms of profitability, MDEVY's ROE is +0.73%, compared to GHIFF's ROE of +0.17%. Regarding short-term risk, MDEVY is more volatile compared to GHIFF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GHIFF's competition here
MDEVY vs PBTHF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PBTHF has a market cap of 156.4M. Regarding current trading prices, MDEVY is priced at $2.23, while PBTHF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PBTHF's P/E ratio is -9.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to PBTHF's ROE of +6.53%. Regarding short-term risk, MDEVY is less volatile compared to PBTHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check PBTHF's competition here
MDEVY vs EHGRF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EHGRF has a market cap of 127.9M. Regarding current trading prices, MDEVY is priced at $2.23, while EHGRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EHGRF's P/E ratio is -0.80. In terms of profitability, MDEVY's ROE is +0.73%, compared to EHGRF's ROE of -0.57%. Regarding short-term risk, MDEVY is more volatile compared to EHGRF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check EHGRF's competition here
MDEVY vs PMKRF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PMKRF has a market cap of 124.4M. Regarding current trading prices, MDEVY is priced at $2.23, while PMKRF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PMKRF's P/E ratio is -27.08. In terms of profitability, MDEVY's ROE is +0.73%, compared to PMKRF's ROE of -0.14%. Regarding short-term risk, MDEVY is more volatile compared to PMKRF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PMKRF's competition here
MDEVY vs PSDMF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PSDMF has a market cap of 114.9M. Regarding current trading prices, MDEVY is priced at $2.23, while PSDMF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PSDMF's P/E ratio is 14.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to PSDMF's ROE of +0.15%. Regarding short-term risk, MDEVY is more volatile compared to PSDMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check PSDMF's competition here
MDEVY vs RCTUF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, RCTUF has a market cap of 112.6M. Regarding current trading prices, MDEVY is priced at $2.23, while RCTUF trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas RCTUF's P/E ratio is 18.83. In terms of profitability, MDEVY's ROE is +0.73%, compared to RCTUF's ROE of +0.54%. Regarding short-term risk, MDEVY is more volatile compared to RCTUF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check RCTUF's competition here
MDEVY vs GIGI Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GIGI has a market cap of 95.6M. Regarding current trading prices, MDEVY is priced at $2.23, while GIGI trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GIGI's P/E ratio is 17.75. In terms of profitability, MDEVY's ROE is +0.73%, compared to GIGI's ROE of +0.00%. Regarding short-term risk, MDEVY is more volatile compared to GIGI. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GIGI's competition here
MDEVY vs PDSSF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, PDSSF has a market cap of 72.5M. Regarding current trading prices, MDEVY is priced at $2.23, while PDSSF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas PDSSF's P/E ratio is 1.38. In terms of profitability, MDEVY's ROE is +0.73%, compared to PDSSF's ROE of +0.28%. Regarding short-term risk, MDEVY is less volatile compared to PDSSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check PDSSF's competition here
MDEVY vs GLXZ Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GLXZ has a market cap of 41.8M. Regarding current trading prices, MDEVY is priced at $2.23, while GLXZ trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GLXZ's P/E ratio is 8.68. In terms of profitability, MDEVY's ROE is +0.73%, compared to GLXZ's ROE of -0.27%. Regarding short-term risk, MDEVY is more volatile compared to GLXZ. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GLXZ's competition here
MDEVY vs ARHN Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ARHN has a market cap of 34.8M. Regarding current trading prices, MDEVY is priced at $2.23, while ARHN trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ARHN's P/E ratio is -50.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to ARHN's ROE of -0.02%. Regarding short-term risk, MDEVY is more volatile compared to ARHN. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check ARHN's competition here
MDEVY vs BRRE Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BRRE has a market cap of 23.7M. Regarding current trading prices, MDEVY is priced at $2.23, while BRRE trades at $9.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BRRE's P/E ratio is -492.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to BRRE's ROE of -0.04%. Regarding short-term risk, MDEVY is more volatile compared to BRRE. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check BRRE's competition here
MDEVY vs WNRS Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, WNRS has a market cap of 21.3M. Regarding current trading prices, MDEVY is priced at $2.23, while WNRS trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas WNRS's P/E ratio is -66.92. In terms of profitability, MDEVY's ROE is +0.73%, compared to WNRS's ROE of +2.45%. Regarding short-term risk, MDEVY is more volatile compared to WNRS. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check WNRS's competition here
MDEVY vs TBTC Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, TBTC has a market cap of 20.8M. Regarding current trading prices, MDEVY is priced at $2.23, while TBTC trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas TBTC's P/E ratio is 11.46. In terms of profitability, MDEVY's ROE is +0.73%, compared to TBTC's ROE of +0.14%. Regarding short-term risk, MDEVY is more volatile compared to TBTC. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check TBTC's competition here
MDEVY vs CTTMF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, CTTMF has a market cap of 14.8M. Regarding current trading prices, MDEVY is priced at $2.23, while CTTMF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas CTTMF's P/E ratio is -1.15. In terms of profitability, MDEVY's ROE is +0.73%, compared to CTTMF's ROE of -0.09%. Regarding short-term risk, MDEVY is less volatile compared to CTTMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check CTTMF's competition here
MDEVY vs JKPTF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, JKPTF has a market cap of 14.7M. Regarding current trading prices, MDEVY is priced at $2.23, while JKPTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas JKPTF's P/E ratio is -0.86. In terms of profitability, MDEVY's ROE is +0.73%, compared to JKPTF's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to JKPTF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check JKPTF's competition here
MDEVY vs MALDF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, MALDF has a market cap of 14.6M. Regarding current trading prices, MDEVY is priced at $2.23, while MALDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas MALDF's P/E ratio is -0.06. In terms of profitability, MDEVY's ROE is +0.73%, compared to MALDF's ROE of -1.02%. Regarding short-term risk, MDEVY is less volatile compared to MALDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check MALDF's competition here
MDEVY vs JPOTF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, JPOTF has a market cap of 11.1M. Regarding current trading prices, MDEVY is priced at $2.23, while JPOTF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas JPOTF's P/E ratio is -1.87. In terms of profitability, MDEVY's ROE is +0.73%, compared to JPOTF's ROE of +1.28%. Regarding short-term risk, MDEVY is more volatile compared to JPOTF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check JPOTF's competition here
MDEVY vs TNTAF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, TNTAF has a market cap of 11M. Regarding current trading prices, MDEVY is priced at $2.23, while TNTAF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas TNTAF's P/E ratio is -2.60. In terms of profitability, MDEVY's ROE is +0.73%, compared to TNTAF's ROE of -2.83%. Regarding short-term risk, MDEVY is more volatile compared to TNTAF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check TNTAF's competition here
MDEVY vs SPOZF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SPOZF has a market cap of 8.6M. Regarding current trading prices, MDEVY is priced at $2.23, while SPOZF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SPOZF's P/E ratio is -14.33. In terms of profitability, MDEVY's ROE is +0.73%, compared to SPOZF's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to SPOZF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check SPOZF's competition here
MDEVY vs NWGIW Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, NWGIW has a market cap of 5.8M. Regarding current trading prices, MDEVY is priced at $2.23, while NWGIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas NWGIW's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to NWGIW's ROE of -1.47%. Regarding short-term risk, MDEVY is more volatile compared to NWGIW. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check NWGIW's competition here
MDEVY vs CETMF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, CETMF has a market cap of 4.6M. Regarding current trading prices, MDEVY is priced at $2.23, while CETMF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas CETMF's P/E ratio is -0.03. In terms of profitability, MDEVY's ROE is +0.73%, compared to CETMF's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to CETMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check CETMF's competition here
MDEVY vs LTFD Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, LTFD has a market cap of 3.5M. Regarding current trading prices, MDEVY is priced at $2.23, while LTFD trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas LTFD's P/E ratio is -4.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to LTFD's ROE of +0.01%. Regarding short-term risk, MDEVY is more volatile compared to LTFD. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check LTFD's competition here
MDEVY vs RYWCF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, RYWCF has a market cap of 3.5M. Regarding current trading prices, MDEVY is priced at $2.23, while RYWCF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas RYWCF's P/E ratio is -0.56. In terms of profitability, MDEVY's ROE is +0.73%, compared to RYWCF's ROE of +2.20%. Regarding short-term risk, MDEVY is more volatile compared to RYWCF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check RYWCF's competition here
MDEVY vs ITMZF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ITMZF has a market cap of 2.2M. Regarding current trading prices, MDEVY is priced at $2.23, while ITMZF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ITMZF's P/E ratio is -0.02. In terms of profitability, MDEVY's ROE is +0.73%, compared to ITMZF's ROE of -3.05%. Regarding short-term risk, MDEVY is less volatile compared to ITMZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check ITMZF's competition here
MDEVY vs THRSF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, THRSF has a market cap of 1.9M. Regarding current trading prices, MDEVY is priced at $2.23, while THRSF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas THRSF's P/E ratio is 1.50. In terms of profitability, MDEVY's ROE is +0.73%, compared to THRSF's ROE of +3.13%. Regarding short-term risk, MDEVY is less volatile compared to THRSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check THRSF's competition here
MDEVY vs FCNE Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, FCNE has a market cap of 1.9M. Regarding current trading prices, MDEVY is priced at $2.23, while FCNE trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas FCNE's P/E ratio is -1.11. In terms of profitability, MDEVY's ROE is +0.73%, compared to FCNE's ROE of -0.25%. Regarding short-term risk, MDEVY is more volatile compared to FCNE. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check FCNE's competition here
MDEVY vs ELRA Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ELRA has a market cap of 1.3M. Regarding current trading prices, MDEVY is priced at $2.23, while ELRA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ELRA's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to ELRA's ROE of -0.29%. Regarding short-term risk, MDEVY is more volatile compared to ELRA. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check ELRA's competition here
MDEVY vs KNBA Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, KNBA has a market cap of 1.2M. Regarding current trading prices, MDEVY is priced at $2.23, while KNBA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas KNBA's P/E ratio is 0.09. In terms of profitability, MDEVY's ROE is +0.73%, compared to KNBA's ROE of -0.30%. Regarding short-term risk, MDEVY is more volatile compared to KNBA. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check KNBA's competition here
MDEVY vs BRVO Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, BRVO has a market cap of 1.2M. Regarding current trading prices, MDEVY is priced at $2.23, while BRVO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas BRVO's P/E ratio is -2.50. In terms of profitability, MDEVY's ROE is +0.73%, compared to BRVO's ROE of +0.19%. Regarding short-term risk, MDEVY is less volatile compared to BRVO. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check BRVO's competition here
MDEVY vs RVRVF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, RVRVF has a market cap of 923.3K. Regarding current trading prices, MDEVY is priced at $2.23, while RVRVF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas RVRVF's P/E ratio is -1.01. In terms of profitability, MDEVY's ROE is +0.73%, compared to RVRVF's ROE of -1.48%. Regarding short-term risk, MDEVY is more volatile compared to RVRVF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check RVRVF's competition here
MDEVY vs GMER Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, GMER has a market cap of 890.9K. Regarding current trading prices, MDEVY is priced at $2.23, while GMER trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas GMER's P/E ratio is -0.69. In terms of profitability, MDEVY's ROE is +0.73%, compared to GMER's ROE of +0.41%. Regarding short-term risk, MDEVY is more volatile compared to GMER. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check GMER's competition here
MDEVY vs VETIF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, VETIF has a market cap of 841.9K. Regarding current trading prices, MDEVY is priced at $2.23, while VETIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas VETIF's P/E ratio is -0.43. In terms of profitability, MDEVY's ROE is +0.73%, compared to VETIF's ROE of +9.04%. Regarding short-term risk, MDEVY is less volatile compared to VETIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check VETIF's competition here
MDEVY vs FUNFF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, FUNFF has a market cap of 251.7K. Regarding current trading prices, MDEVY is priced at $2.23, while FUNFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas FUNFF's P/E ratio is -0.02. In terms of profitability, MDEVY's ROE is +0.73%, compared to FUNFF's ROE of -0.52%. Regarding short-term risk, MDEVY is more volatile compared to FUNFF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check FUNFF's competition here
MDEVY vs RVLCF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, RVLCF has a market cap of 235.6K. Regarding current trading prices, MDEVY is priced at $2.23, while RVLCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas RVLCF's P/E ratio is -0.02. In terms of profitability, MDEVY's ROE is +0.73%, compared to RVLCF's ROE of +0.65%. Regarding short-term risk, MDEVY is more volatile compared to RVLCF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check RVLCF's competition here
MDEVY vs EMBR Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EMBR has a market cap of 132.1K. Regarding current trading prices, MDEVY is priced at $2.23, while EMBR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EMBR's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to EMBR's ROE of +0.10%. Regarding short-term risk, MDEVY is less volatile compared to EMBR. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check EMBR's competition here
MDEVY vs EXPH Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EXPH has a market cap of 100K. Regarding current trading prices, MDEVY is priced at $2.23, while EXPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EXPH's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to EXPH's ROE of N/A. Regarding short-term risk, MDEVY is less volatile compared to EXPH. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check EXPH's competition here
MDEVY vs SWCC Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, SWCC has a market cap of 75.9K. Regarding current trading prices, MDEVY is priced at $2.23, while SWCC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas SWCC's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to SWCC's ROE of +6.96%. Regarding short-term risk, MDEVY is less volatile compared to SWCC. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check SWCC's competition here
MDEVY vs EPGG Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EPGG has a market cap of 29.8K. Regarding current trading prices, MDEVY is priced at $2.23, while EPGG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EPGG's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to EPGG's ROE of +1.36%. Regarding short-term risk, MDEVY is more volatile compared to EPGG. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check EPGG's competition here
MDEVY vs NTGL Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, NTGL has a market cap of 18.2K. Regarding current trading prices, MDEVY is priced at $2.23, while NTGL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas NTGL's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to NTGL's ROE of -2.11%. Regarding short-term risk, MDEVY is more volatile compared to NTGL. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check NTGL's competition here
MDEVY vs ELYS Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ELYS has a market cap of 3.7K. Regarding current trading prices, MDEVY is priced at $2.23, while ELYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ELYS's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to ELYS's ROE of -1.47%. Regarding short-term risk, MDEVY is more volatile compared to ELYS. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check ELYS's competition here
MDEVY vs AMRA Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, AMRA has a market cap of 3.2K. Regarding current trading prices, MDEVY is priced at $2.23, while AMRA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas AMRA's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to AMRA's ROE of N/A. Regarding short-term risk, MDEVY is less volatile compared to AMRA. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check AMRA's competition here
MDEVY vs CGAM Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, CGAM has a market cap of 2.5K. Regarding current trading prices, MDEVY is priced at $2.23, while CGAM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas CGAM's P/E ratio is -0.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to CGAM's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to CGAM. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check CGAM's competition here
MDEVY vs ULSP Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ULSP has a market cap of 1K. Regarding current trading prices, MDEVY is priced at $2.23, while ULSP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ULSP's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to ULSP's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to ULSP. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check ULSP's competition here
MDEVY vs LUKEF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, LUKEF has a market cap of 689. Regarding current trading prices, MDEVY is priced at $2.23, while LUKEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas LUKEF's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to LUKEF's ROE of -0.92%. Regarding short-term risk, MDEVY is less volatile compared to LUKEF. This indicates potentially lower risk in terms of short-term price fluctuations for MDEVY.Check LUKEF's competition here
MDEVY vs ROBK Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, ROBK has a market cap of 612. Regarding current trading prices, MDEVY is priced at $2.23, while ROBK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas ROBK's P/E ratio is -0.01. In terms of profitability, MDEVY's ROE is +0.73%, compared to ROBK's ROE of +0.34%. Regarding short-term risk, MDEVY is more volatile compared to ROBK. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check ROBK's competition here
MDEVY vs LTTGF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, LTTGF has a market cap of 128. Regarding current trading prices, MDEVY is priced at $2.23, while LTTGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas LTTGF's P/E ratio is N/A. In terms of profitability, MDEVY's ROE is +0.73%, compared to LTTGF's ROE of +3.33%. Regarding short-term risk, MDEVY is more volatile compared to LTTGF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check LTTGF's competition here
MDEVY vs MLCOF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, MLCOF has a market cap of 0. Regarding current trading prices, MDEVY is priced at $2.23, while MLCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas MLCOF's P/E ratio is -0.13. In terms of profitability, MDEVY's ROE is +0.73%, compared to MLCOF's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to MLCOF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check MLCOF's competition here
MDEVY vs EVGEF Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, EVGEF has a market cap of 0. Regarding current trading prices, MDEVY is priced at $2.23, while EVGEF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas EVGEF's P/E ratio is 4.00. In terms of profitability, MDEVY's ROE is +0.73%, compared to EVGEF's ROE of N/A. Regarding short-term risk, MDEVY is more volatile compared to EVGEF. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check EVGEF's competition here
MDEVY vs CWLDY Comparison June 2026
MDEVY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDEVY stands at 672.2M. In comparison, CWLDY has a market cap of 0. Regarding current trading prices, MDEVY is priced at $2.23, while CWLDY trades at $19.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDEVY currently has a P/E ratio of 7.19, whereas CWLDY's P/E ratio is -27.88. In terms of profitability, MDEVY's ROE is +0.73%, compared to CWLDY's ROE of -0.06%. Regarding short-term risk, MDEVY is more volatile compared to CWLDY. This indicates potentially higher risk in terms of short-term price fluctuations for MDEVY.Check CWLDY's competition here